ⓘ Modotuximab

                                     

ⓘ Modotuximab

Modotuximab is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1.

                                     
  • cancer Mitumomab mab mouse GD3 ganglioside small cell lung carcinoma Modotuximab mab chimeric EGFR extracellular domain III cancer Mogamulizumab Poteligeo